304 related articles for article (PubMed ID: 21949373)
1. Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse.
Crawford F; Stadinski B; Jin N; Michels A; Nakayama M; Pratt P; Marrack P; Eisenbarth G; Kappler JW
Proc Natl Acad Sci U S A; 2011 Oct; 108(40):16729-34. PubMed ID: 21949373
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody blocking the recognition of an insulin peptide-MHC complex modulates type 1 diabetes.
Zhang L; Crawford F; Yu L; Michels A; Nakayama M; Davidson HW; Kappler JW; Eisenbarth GS
Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2656-61. PubMed ID: 24550292
[TBL] [Abstract][Full Text] [Related]
3. Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register.
Stadinski BD; Zhang L; Crawford F; Marrack P; Eisenbarth GS; Kappler JW
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10978-83. PubMed ID: 20534455
[TBL] [Abstract][Full Text] [Related]
4. How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes.
Wang Y; Sosinowski T; Novikov A; Crawford F; White J; Jin N; Liu Z; Zou J; Neau D; Davidson HW; Nakayama M; Kwok WW; Gapin L; Marrack P; Kappler JW; Dai S
Sci Immunol; 2019 Apr; 4(34):. PubMed ID: 30952805
[TBL] [Abstract][Full Text] [Related]
5. Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes.
Zhang L; Sosinowski T; Cox AR; Cepeda JR; Sekhar NS; Hartig SM; Miao D; Yu L; Pietropaolo M; Davidson HW
J Autoimmun; 2019 Jan; 96():50-58. PubMed ID: 30122420
[TBL] [Abstract][Full Text] [Related]
6. Ex vivo analysis of thymic CD4 T cells in nonobese diabetic mice with tetramers generated from I-A(g7)/class II-associated invariant chain peptide precursors.
Jang MH; Seth NP; Wucherpfennig KW
J Immunol; 2003 Oct; 171(8):4175-86. PubMed ID: 14530340
[TBL] [Abstract][Full Text] [Related]
7. N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetes.
Jin N; Wang Y; Crawford F; White J; Marrack P; Dai S; Kappler JW
Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13318-23. PubMed ID: 26453556
[TBL] [Abstract][Full Text] [Related]
8. Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion.
Mohan JF; Petzold SJ; Unanue ER
J Exp Med; 2011 Nov; 208(12):2375-83. PubMed ID: 22065673
[TBL] [Abstract][Full Text] [Related]
9. Recognition of Multiple Hybrid Insulin Peptides by a Single Highly Diabetogenic T-Cell Receptor.
Parras D; Solé P; Delong T; Santamaría P; Serra P
Front Immunol; 2021; 12():737428. PubMed ID: 34527002
[TBL] [Abstract][Full Text] [Related]
10. Autoreactive T cells specific for insulin B:11-23 recognize a low-affinity peptide register in human subjects with autoimmune diabetes.
Yang J; Chow IT; Sosinowski T; Torres-Chinn N; Greenbaum CJ; James EA; Kappler JW; Davidson HW; Kwok WW
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14840-5. PubMed ID: 25267644
[TBL] [Abstract][Full Text] [Related]
11. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
[TBL] [Abstract][Full Text] [Related]
12. C-terminal modification of the insulin B:11-23 peptide creates superagonists in mouse and human type 1 diabetes.
Wang Y; Sosinowski T; Novikov A; Crawford F; Neau DB; Yang J; Kwok WW; Marrack P; Kappler JW; Dai S
Proc Natl Acad Sci U S A; 2018 Jan; 115(1):162-167. PubMed ID: 29255035
[TBL] [Abstract][Full Text] [Related]
13. Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers.
Liu CP; Jiang K; Wu CH; Lee WH; Lin WJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14596-601. PubMed ID: 11106373
[TBL] [Abstract][Full Text] [Related]
14. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
[TBL] [Abstract][Full Text] [Related]
15. A novel pathway of presentation by class II-MHC molecules involving peptides or denatured proteins important in autoimmunity.
Mohan JF; Unanue ER
Mol Immunol; 2013 Sep; 55(2):166-8. PubMed ID: 23200226
[TBL] [Abstract][Full Text] [Related]
16. Regulatory vs. inflammatory cytokine T-cell responses to mutated insulin peptides in healthy and type 1 diabetic subjects.
Nakayama M; McDaniel K; Fitzgerald-Miller L; Kiekhaefer C; Snell-Bergeon JK; Davidson HW; Rewers M; Yu L; Gottlieb P; Kappler JW; Michels A
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4429-34. PubMed ID: 25831495
[TBL] [Abstract][Full Text] [Related]
17. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
[TBL] [Abstract][Full Text] [Related]
18. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
[TBL] [Abstract][Full Text] [Related]
19. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice.
Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N
Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281
[TBL] [Abstract][Full Text] [Related]
20. Regulatory and effector CD4 T cells in nonobese diabetic mice recognize overlapping determinants on glutamic acid decarboxylase and use distinct V beta genes.
Quinn A; McInerney B; Reich EP; Kim O; Jensen KP; Sercarz EE
J Immunol; 2001 Mar; 166(5):2982-91. PubMed ID: 11207247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
